AMS May Enter Permanent Birth-Control Market Via Merger Or License
This article was originally published in The Gray Sheet
Executive Summary
Conceptus has less than three weeks to decide whether to purchase Ovion or to allow the transcervical sterilization device developer to merge with American Medical Systems
You may also be interested in...
Cytyc’s Purchase Of Adiana Opens Door To Female Contraception Market
Cytyc could gain PMA approval by year-end for its newly acquired, non-incisional alternative to tubal ligation for permanent female contraception, according to the company
Cytyc’s Purchase Of Adiana Opens Door To Female Contraception Market
Cytyc could gain PMA approval by year-end for its newly acquired, non-incisional alternative to tubal ligation for permanent female contraception, according to the company
Promotion Pact Broadens Conceptus’ Market For Birth-Control Device
Conceptus is redoubling efforts to sell non-incisional birth control to physician offices after failing to acquire Ovion